UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

The Lancet infectious diseases, 2018-02, Vol.18 (2), p.171-179

2018

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12 ‐related autoinflammatory disorder—A case report

Pediatric allergy and immunology, 2023-09, Vol.34 (9)

2023

Volltextzugriff (PDF)

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

The Lancet infectious diseases, 2021-05, Vol.21 (5), p.688-696

2021

Volltextzugriff (PDF)

Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing

Vaccine, 2020-11, Vol.38 (49), p.7834-7841

2020

Volltextzugriff (PDF)

Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment

Frontiers in pediatrics, 2023-06, Vol.11, p.1200401

2023

Volltextzugriff (PDF)

Precision medicine: The use of tailored therapy in primary immunodeficiencies

Frontiers in immunology, 2022-12, Vol.13, p.1029560

2022

Volltextzugriff (PDF)

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis

Nature communications, 2024-03, Vol.15 (1), p.2133-2133, Article 2133

2024

Volltextzugriff (PDF)

Motivations for paediatric vaccine trial participation

Trials, 2023-09, Vol.24 (1), p.574-574, Article 574

2023

Volltextzugriff (PDF)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries

Frontiers in immunology, 2022-05, Vol.13, p.864674-864674

2022

Volltextzugriff (PDF)

Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer

Journal of neuro-oncology, 2018, Vol.136 (1), p.163-171

2018

Volltextzugriff (PDF)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom

EBioMedicine, 2021-03, Vol.65, p.103247-103247, Article 103247

2021

Volltextzugriff (PDF)

Recurrent pyogenic infections caused by a novel Gln1420 mutation in the C3 gene

Frontiers in pediatrics, 2022-10, Vol.10

2022

Volltextzugriff (PDF)

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants

Open forum infectious diseases, 2020-05, Vol.7 (5), p.ofaa143-ofaa143

2020

Volltextzugriff (PDF)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’

EBioMedicine, 2021-06, Vol.68, p.103420-103420, Article 103420

2021

Volltextzugriff (PDF)

Immunisation of the immunocompromised child

The Journal of infection, 2016-07, Vol.72, p.S13-S22

2016

Volltextzugriff (PDF)

Understanding Immunity Differences Induced by Whole Cell and Acellular Pertussis Vaccines in a Paediatric Population

Martins Valente Pinto, Ana Marta

2021

Volltextzugriff (PDF)

Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12-related autoinflammatory disorder-A case report

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2023, Vol.34 (9), p.e14020-e14020

2023

Volltextzugriff (PDF)

Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment

Frontiers in pediatrics, 2023, Vol.11, p.1200401-1200401

2023

Volltextzugriff (PDF)

Recurrent pyogenic infections caused by a novel Gln1420 mutation in the C3 gene

Frontiers in pediatrics, 2022, Vol.10, p.1017195-1017195

2022

Volltextzugriff (PDF)

Hemophagocytic syndrome with atypical presentation in an adolescent

BMJ Case Reports, 2013, Vol.2013

2013

Volltextzugriff (PDF)

Adequate Responses to an Acellular Pertussis Booster Vaccination in Children, Adolescents, and Young and Older Adults: A Collaborative Study in Finland, the Netherlands, and the United Kingdom

SSRN Electronic Journal

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(19)

Publikationsform

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12 ‐related autoinflammatory disorder—A case report

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing

Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment

Precision medicine: The use of tailored therapy in primary immunodeficiencies

Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis

Motivations for paediatric vaccine trial participation

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries

Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom

Recurrent pyogenic infections caused by a novel Gln1420 mutation in the C3 gene

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’

Immunisation of the immunocompromised child

Understanding Immunity Differences Induced by Whole Cell and Acellular Pertussis Vaccines in a Paediatric Population

Hemophagocytic lymphohistiocytosis in an adolescent with NLRP12-related autoinflammatory disorder-A case report

Case Report: Patient with deficiency of ADA2 presenting leukocytoclastic vasculitis and pericarditis during infliximab treatment

Recurrent pyogenic infections caused by a novel Gln1420 mutation in the C3 gene

Hemophagocytic syndrome with atypical presentation in an adolescent

Adequate Responses to an Acellular Pertussis Booster Vaccination in Children, Adolescents, and Young and Older Adults: A Collaborative Study in Finland, the Netherlands, and the United Kingdom

Suchergebnisse filtern